Collegium's General Counsel Trims His Stake as the Company Doubles Down on ADHD [Yahoo! Finance]
Collegium Pharmaceutical, Inc. (COLL)
Last collegium pharmaceutical, inc. earnings: 2/27 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.collegiumpharma.com
Company Research
Source: Yahoo! Finance
Pharmaceutical (NASDAQ:COLL) , reported the sale of 6,224 shares of common stock in an open-market transaction on March 9, 2026, according to a SEC Form 4 filing Transaction summary Metric Value Shares sold (direct) Transaction value Post-transaction shares (direct) Post-transaction value (direct ownership) $3.39 million Transaction value based on SEC Form 4 reported price ($36.65); post-transaction value based on March 9, 2026 market close price. Key questions How does the size of this sale compare to the insider's prior trading activity? Dieter joined Collegium in March 2025 and this is his first open-market sale on record.There's not enough data to establish a pattern. What proportion of the insider's stake was affected by this transaction? The sale accounted for 6.40% of David's direct equity stake, reducing his direct holdings from 97,271 to 91,047 shares. Does the insider maintain a material ongoing position after this sale? Yes. Dieter retains 91
Show less
Read more
Impact Snapshot
Event Time:
COLL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
COLL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
COLL alerts
High impacting Collegium Pharmaceutical, Inc. news events
Weekly update
A roundup of the hottest topics
COLL
News
- 1 Value Stock on Our Buy List and 2 Facing Headwinds [Yahoo! Finance]Yahoo! Finance
- 2 Profitable Stocks to Consider Right Now and 1 We Question [Yahoo! Finance]Yahoo! Finance
- Is Collegium Pharmaceutical (COLL) One of the Best Small-Cap Drug Manufacturers [Yahoo! Finance]Yahoo! Finance
- Branded Pharmaceuticals Stocks Q4 Recap: Benchmarking Collegium Pharmaceutical (NASDAQ:COLL) [Yahoo! Finance]Yahoo! Finance
- Collegium Pharmaceutical (COLL) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $56.00 price target on the stock, up from $54.00.MarketBeat
COLL
Earnings
- 2/26/26 - Beat
COLL
Sec Filings
- 4/3/26 - Form 4
- 3/26/26 - Form SCHEDULE
- 3/20/26 - Form 4
- COLL's page on the SEC website